BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22573409)

  • 1. Laboratory identification of lupus anticoagulants.
    Kershaw G; Suresh S; Orellana D; Nguy YM
    Semin Thromb Hemost; 2012 Jun; 38(4):375-84. PubMed ID: 22573409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of lupus anticoagulants: an update on quality in laboratory testing.
    Adams M
    Semin Thromb Hemost; 2013 Apr; 39(3):267-71. PubMed ID: 23424052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are laboratories following published recommendations for lupus anticoagulant testing? An international evaluation of practices.
    Moffat KA; Ledford-Kraemer MR; Plumhoff EA; McKay H; Nichols WL; Meijer P; Hayward CP
    Thromb Haemost; 2009 Jan; 101(1):178-84. PubMed ID: 19132206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To mix or not to mix in lupus anticoagulant testing? That is the question.
    Tripodi A
    Semin Thromb Hemost; 2012 Jun; 38(4):385-9. PubMed ID: 22618530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory testing for lupus anticoagulants: pre-examination variables, mixing studies, and diagnostic criteria.
    Ledford-Kraemer MR
    Semin Thromb Hemost; 2008 Jun; 34(4):380-8. PubMed ID: 18814072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dilution effect of equal volume mixing studies compromises confirmation of inhibition by lupus anticoagulants even when mixture specific reference ranges are applied.
    Moore GW; Savidge GF
    Thromb Res; 2006; 118(4):523-8. PubMed ID: 16263154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commonalities and contrasts in recent guidelines for lupus anticoagulant detection.
    Moore GW
    Int J Lab Hematol; 2014 Jun; 36(3):364-73. PubMed ID: 24750683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lupus anticoagulant testing in Europe: an analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2-glycoprotein I.
    Arnout J; Meijer P; Vermylen J
    Thromb Haemost; 1999 Jun; 81(6):929-34. PubMed ID: 10404770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory identification of lupus anticoagulants.
    Smock KJ; Rodgers GM
    Am J Hematol; 2009 Jul; 84(7):440-2. PubMed ID: 19384933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New guidelines for lupus anticoagulant: sensitivity and specificity of cut-off values calculated with plasmas from healthy controls in mixing and confirmatory tests.
    Martinuzzo ME; Cerrato GS; Varela ML; Adamczuk YP; Forastiero RR
    Int J Lab Hematol; 2012 Apr; 34(2):208-13. PubMed ID: 22032515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lupus anticoagulants: diagnostic dilemma and clinical challenge.
    Triplett DA
    Clin Lab Sci; 1997; 10(4):223-8. PubMed ID: 10169622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent guidelines and recommendations for laboratory detection of lupus anticoagulants.
    Moore GW
    Semin Thromb Hemost; 2014 Mar; 40(2):163-71. PubMed ID: 24500573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conceptions and misconceptions in testing for lupus anticoagulants.
    Exner T
    J Autoimmun; 2000 Sep; 15(2):179-83. PubMed ID: 10968906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating laboratory approaches to the identification of lupus anticoagulants: a diagnostic challenge from the RCPA Haematology QAP.
    Bonar R; Favaloro E; Zebeljan D; Rosenfeld D; Kershaw G; Mohammed S; Marsden K; Hertzberg M
    Pathology; 2012 Apr; 44(3):240-7. PubMed ID: 22183703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lupus anticoagulant testing: performance and practices by north american clinical laboratories.
    Dembitzer FR; Ledford Kraemer MR; Meijer P; Peerschke EI
    Am J Clin Pathol; 2010 Nov; 134(5):764-73. PubMed ID: 20959659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the reagent "IL Test LAC Screen/IL Test LAC Confirm" for the biological diagnosis of circulating lupus anticoagulants].
    Magdelaine A; Verdy E
    Ann Biol Clin (Paris); 1996; 54(7):293-6. PubMed ID: 8952726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixing test specific cut-off is more sensitive at detecting lupus anticoagulants than index of circulating anticoagulant.
    Moore GW; Culhane AP; Daw CR; Noronha CP; Kumano O
    Thromb Res; 2016 Mar; 139():98-101. PubMed ID: 26916303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a modified procedure for Staclot LA for the confirmation of lupus anticoagulants.
    Charles LA; McGlasson DL; Hawksworth BA; Ashcraft JH; Ortel TL
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):601-4. PubMed ID: 7841317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimisation of lupus anticoagulant tests: should test samples always be mixed with normal plasma?
    Pennings MT; De Groot PG; Meijers JC; Huisman A; Derksen RH; Urbanus RT
    Thromb Haemost; 2014 Oct; 112(4):736-42. PubMed ID: 25008787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic methodologies for circulating anticoagulants.
    Exner T
    Thromb Haemost; 1995 Jul; 74(1):338-44. PubMed ID: 8578481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.